Simon Faissner MD
Consultant in Neurology, Assistant Professor (W1), Ruhr-University Bochum; Department of Neurology and Center for Neuroimmunology, St. Josef-Hospital, Bochum, Germany
Dr. Simon Faissner is a neurologist with focus on neuroimmunology. He studied medicine in Bochum (Germany), Strasbourg (France) and London (Great Britain) and was trained in Neurology at the Department of Neurology, Ruhr-University Bochum/Germany under the supervision of Prof. Ralf Gold. During his research career, he performed a post-doc at the University of Calgary in 2016 under the mentorship of Prof. V. Wee Yong. Since 2017 he is Consultant Neurologist in the department of Prof. Gold and a group leader in the Center of Neuroimmunology (director Prof. Gold) and holds an assistant professorship for Translational Neuroimmunology since 2019 at Ruhr-University Bochum.
His research focusses on the immunological and neurodegenerative mechanisms underlying chronic inflammation in multiple sclerosis and other inflammatory CNS disorders as well as the development of therapeutic approaches to target chronic inflammation and enhance neuroprotection in a translational approach.
His research focusses on the immunological and neurodegenerative mechanisms underlying chronic inflammation in multiple sclerosis and other inflammatory CNS disorders as well as the development of therapeutic approaches to target chronic inflammation and enhance neuroprotection in a translational approach.
Disclosures
Dr. Faissner received travel grants from Biogen Idec and Genzyme, speaker or board honoraria from Novartis and Celgene, and research support from Novartis, all not related to the content of this manuscript.